Skip to main content
OpenTrials

Clinical trial condition

Essential Thrombocythemia

Explore clinical trials studying Essential Thrombocythemia. Study availability and eligibility vary by location and protocol.

72 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Essential Thrombocythemia trial results

Recruiting

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

NCT06661915

Conditions
Accelerated Phase Myeloproliferative Neoplasm, Blast Phase Myeloproliferative Neoplasm, Blood Coagulation Disorders, +19 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 31 locations
View Trial Details
Recruiting

A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

NCT07623200

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Banner Md Anderson Cancer Center Gilbert, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • Marin Cancer Care Greenbrae, California, United States
View all 180 locations
View Trial Details
Recruiting

AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms

NCT05198960

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +24 more
Locations
  • CHU d'Angers Angers, France
  • CH d'Annecy Annecy, France
  • CH d'Argenteuil Argenteuil, France
  • CH d'Avignon Avignon, France
View all 42 locations
View Trial Details
Recruiting

Ruxolitinib in Thrombocythemia and Polycythemia Vera

NCT04644211

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Massachusetts General North Shore Cancer Center Danvers, Massachusetts, United States
View Trial Details
Recruiting

Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET

NCT06552429

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Peking Union Hospital, Chinese Academy of Medical Sciences Beijing, China
  • Peking University People's Hospital Beijing, China
  • Union Hospital affiliated to Fujian Medical University Fujian, China
  • Nanfang Hospital, Southern Medical University Guangzhou, China
View Trial Details

Related conditions